{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61825-305",
      "generic_name": "Orphenadrine Citrate, Aspirin and Caffeine",
      "labeler_name": "Galt Pharmaceuticals, LLC",
      "brand_name": "Norgesic",
      "active_ingredients": [
        {
          "name": "ORPHENADRINE CITRATE",
          "strength": "25 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "385 mg/1"
        },
        {
          "name": "CAFFEINE",
          "strength": "30 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "61825-305-60",
          "description": "60 TABLET in 1 BOTTLE, PLASTIC (61825-305-60)",
          "marketing_start_date": "20220516",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Galt Pharmaceuticals, LLC"
        ],
        "rxcui": [
          "994528",
          "994530"
        ],
        "spl_set_id": [
          "be2761bc-e537-4039-846a-2ffa3d8b2afc"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832",
          "N0000175739",
          "N0000175729",
          "N0000175790",
          "M0023046"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]",
          "Central Nervous System Stimulation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]",
          "Xanthines [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]",
          "Central Nervous System Stimulant [EPC]",
          "Methylxanthine [EPC]"
        ],
        "unii": [
          "X0A40N8I4S",
          "R16CO5Y76E",
          "3G6A5W338E"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "47da9e12-c9c2-d80e-e063-6294a90a86aa",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220516",
      "product_id": "61825-305_47da9e12-c9c2-d80e-e063-6294a90a86aa",
      "application_number": "ANDA075141",
      "brand_name_base": "Norgesic",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Centrally-mediated Muscle Relaxation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Muscle Relaxant [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}